Wlodarczyk Francis 4

What Happened

• Director Francis Wlodarczyk received an award of 5,556 restricted share units (RSUs) on March 12, 2026. The grant is reported as a derivative award (code A) with a reported grant price of $0.00; the issuer used $25.23 (the mean of the high and low Nasdaq price that day) to value the award, implying an approximate grant value of $140,178.
• These RSUs represent a contingent right to one share of the company’s Class A common stock each and generally vest on March 12, 2028, at which time each unit will convert to one share.

Key Details

• Transaction date: 2026-03-12; Form 4 filed 2026-03-13 (timely — within reporting window).
• Grant: 5,556 RSUs; per-share valuation used: $25.23; implied total ≈ $140,178.
• Vesting: Generally vests March 12, 2028 (see footnote F3).
• Footnotes: F1 = RSUs are under the Second Amended and Restated 2019 Director Fee Plan and convert 1:1 to shares; F2 = number calculated using mean price $25.23; F3 = vest date 3/12/2028. A Power of Attorney dated 6/20/2025 was previously filed and is incorporated by reference.
• Shares owned after transaction: Not specified in the provided filing excerpt.

Context

• This is a typical director compensation grant (RSUs), not an open-market purchase or sale. RSUs do not deliver shares or cash until they vest, so this award does not represent an immediate sale or buy signal.
• For retail investors tracking insider activity, compensation grants indicate how the company remunerates directors but do not directly signal a director’s short-term trading conviction.